These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9809893

  • 21. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD.
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS, Lundergan CF, van den Brand M, Boland J, Thompson MA, Machecourt J, Py A, Pilcher GS, Fink CA, Burton JR.
    J Am Coll Cardiol; 1994 Nov 15; 24(6):1439-44. PubMed ID: 7930273
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 15; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 27. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators.
    N Engl J Med; 1993 Nov 25; 329(22):1615-22. PubMed ID: 8232430
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.
    Wong CK, Gao W, Raffel OC, French JK, Stewart RA, White HD, HERO-2 Investigators.
    Lancet; 2006 Jun 24; 367(9528):2061-7. PubMed ID: 16798389
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Zeymer U, Neuhaus KL.
    Z Kardiol; 2000 Jun 24; 89 Suppl 4():IV30-40. PubMed ID: 10810775
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. TIMI grade flow, mortality, and the GUSTO-III trial.
    Stringer KA.
    Pharmacotherapy; 1998 Jun 24; 18(4):699-705. PubMed ID: 9692644
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction.
    Wong CK, French JK, Aylward PE, Frey MJ, Adgey AA, White HD.
    Am J Cardiol; 1999 Jan 15; 83(2):164-8. PubMed ID: 10073815
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG, Laperche T, Golmard JL, Juliard JM, Benamer H, Himbert D, Aubry P.
    J Am Coll Cardiol; 1998 Mar 15; 31(4):776-9. PubMed ID: 9525545
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.